Literature DB >> 10602564

Reduction of Platelet Thrombi and Emboli by L-Arginine during Cardiopulmonary Bypass in a Pig Model.

.   

Abstract

We wanted to test the hypothesis that NO generation by L-arginine (LA) infusion will be beneficial in increasing blood flow to all organs to counteract the process of global ischemia during cardiopulmonary bypass (CPB) and to reduce platelet emboli by platelet inhibition. The effect of LA infusion on NO formation, vasodilation, and reduction of thromboembolic burden in organs and tissues after CPB was quantified with In-111-labeled autologous platelets in two major groups: 180 minutes CPB (CPB) and 90 minutes CPB plus 90 minutes reperfusion (RP). Platelets labeled with In-111 tropolone (650-780 µCi) were administered 24 hours before CPB and LA infusion (bolus, 10 mg/kg and infusion at 2 mg/kg/min, 21 pigs for 180 minutes CPB) in 8 groups of 30 Yorkshire pigs (30-35 kg, 6 pigs; LA 2 mg/kg/min, 3 pigs; sham-thoracotomy control, 6 pigs; unoperated control, 6 pigs). Two groups of 9 pigs (control CPB, 6 pigs; LA 2 mg/kg/min, 3 pigs) underwent 90 minutes of CPB and 90 minutes of reperfusion. All pigs were heparinized (ACT > 400 seconds); CPB was instituted with a roller pump, an oxygenator (OX: Bentley Univox, 1.8 m2), and an arterial filter (AF: 0.25 m2, Bentley) at a blood flow of 2.5-3.5 l/min. Radioactive thrombi in OX and AF and emboli in viscera, brain, and connective tissues were imaged with a gamma camera and were finally measured with an ion chamber and a gamma counter. The percent of injected platelets (mean +/- SD) in the organs and tissues of all pigs was calculated. Cerebral emboli were mapped in 25 regions of both hemispheres of pig brain. Flow cytometry with antibodies to CD61 (GPIIIa) and CD62P (GMP-140:control) of porcine platelets was carried out with blood samples taken before, during, and after CPB. Coronary bypass with LA infusion decreased the amount of adherent thrombi in OX and AF (p < 0.07). The embolic burden in brain and lung also decreased. Regional cerebral mapping of In-111 platelets showed reduced emboli in almost all regions, including the medulla, hip pocampus, and posterior cerebral cortex in both LA-treated groups. Flow cytometry of blood samples demonstrated the shift of equilibria from single platelet to platelet-aggregate-microparticle during CPB and steady-state level after the first 5-10 minutes of initiation of CPB. The L-arginine infusion reduced thrombi and emboli during CPB in the pig model.

Entities:  

Year:  1996        PMID: 10602564     DOI: 10.1007/BF00133078

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  50 in total

1.  Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase.

Authors:  D S Bredt; P M Hwang; C E Glatt; C Lowenstein; R R Reed; S H Snyder
Journal:  Nature       Date:  1991-06-27       Impact factor: 49.962

Review 2.  Nitric oxide: pathophysiological mechanisms.

Authors:  S S Gross; M S Wolin
Journal:  Annu Rev Physiol       Date:  1995       Impact factor: 19.318

3.  Synthesis of nitric oxide from L-arginine by neutrophils. Release and interaction with superoxide anion.

Authors:  T B McCall; N K Boughton-Smith; R M Palmer; B J Whittle; S Moncada
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

4.  In vitro and in vivo evaluation of the comparative thrombogenicity of cellulose acetate hemodialyzers with radiolabeled platelets.

Authors:  M K Dewanjee; M Kapadvanjwala; C F Cavagnaro; G K Panoutsopoulos; C Y Suguihara; R Elson; S H Ezuddin; A N Serafini; G E Zilleruelo; G N Sfakianakis
Journal:  ASAIO J       Date:  1994 Jan-Mar       Impact factor: 2.872

5.  Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate.

Authors:  M A Marletta; P S Yoon; R Iyengar; C D Leaf; J S Wishnok
Journal:  Biochemistry       Date:  1988-11-29       Impact factor: 3.162

6.  Indium-111 tropolone, a new high-affinity platelet label: preparation and evaluation of labeling parameters.

Authors:  M K Dewanjee; S A Rao; P Didisheim
Journal:  J Nucl Med       Date:  1981-11       Impact factor: 10.057

7.  A higher blood flow window of reduced thrombogenicity and acceptable fragmentation in a hollow fiber hemodialyzer.

Authors:  M K Dewanjee; M Kapadvanjwala; W W Mao; W Jy; Y Ahn; K Ruzius; A K Ghafouripour; A N Serafini; G N Sfakianakis
Journal:  ASAIO J       Date:  1993 Jul-Sep       Impact factor: 2.872

8.  Comparative real-time effects on platelet adhesion and aggregation under flowing conditions of in vivo aspirin, heparin, and monoclonal antibody fragment against glycoprotein IIb-IIIa.

Authors:  N A Turner; J L Moake; S G Kamat; A I Schafer; N S Kleiman; R Jordan; L V McIntire
Journal:  Circulation       Date:  1995-03-01       Impact factor: 29.690

Review 9.  y(+)-type cationic amino acid transport: expression and regulation of the mCAT genes.

Authors:  C L MacLeod; K D Finley; D K Kakuda
Journal:  J Exp Biol       Date:  1994-11       Impact factor: 3.312

10.  An L-arginine-dependent mechanism mediates Kupffer cell inhibition of hepatocyte protein synthesis in vitro.

Authors:  T R Billiar; R D Curran; D J Stuehr; M A West; B G Bentz; R L Simmons
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.